Pancreatic Cancer Research

ResearcherUniversité Libre de BruxellesActive in the last 2 years

Kosta Stosic

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-2984-034X; OpenAlex author ID A5093529055. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper

Papers 5

  1. Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-dose stereotactic body radiotherapy. Co-author DOI 10.1038/s41416-025-03274-0↗
  2. Glycation Stress–Driven Transcriptomic Signature Predicts Survival Benefit from Adjuvant Gemcitabine in Resectable Pancreatic Cancer First author DOI 10.1101/2025.07.07.663493↗
  3. Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after Total Neoadjuvant Therapy including Stereotactic Body Radiotherapy Co-author DOI 10.1101/2024.04.30.591890↗
  4. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity: From Single-Cell Analysis to Whole-Body Imaging. Co-author DOI 10.3390/biomedicines12030591↗
  5. A Comprehensive Review of the Potential Role of Liquid Biopsy as a Diagnostic, Prognostic, and Predictive Biomarker in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cells13010003↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Julie Navez · 5 shared papers, 2023–2026 · strength 1.00
  2. Christelle Bouchart · 5 shared papers, 2023–2026 · strength 1.00
  3. Oier Azurmendi Senar · 5 shared papers, 2023–2026 · strength 1.00
  4. Tatjana Arsenijevic · 5 shared papers, 2023–2026 · strength 1.00
  5. Jean‐Luc Van Laethem · 4 shared papers, 2023–2026 · strength 0.80
  6. Pieter Demetter · 3 shared papers, 2024–2026 · strength 0.58
  7. Rémy Nicolle · 3 shared papers, 2024–2026 · strength 0.58
  8. Léo Mas · 2 shared papers, 2024–2026 · strength 0.38
  9. Nicky D’Haene · 2 shared papers, 2024–2026 · strength 0.38
  10. Shulin Zhao · 2 shared papers, 2024–2026 · strength 0.38
  11. Matthieu Hein · 2 shared papers, 2024–2026 · strength 0.38
  12. Ilse Rooman · 2 shared papers, 2024–2026 · strength 0.38
  13. Jean‐Baptiste Bachet · 2 shared papers, 2024–2026 · strength 0.38
  14. Ellis Michiels · 1 shared paper, 2026 · strength 0.22
  15. Rita Saúde-Conde · 1 shared paper, 2024 · strength 0.22
  16. Jean-Luc Van-Laethem · 1 shared paper, 2025 · strength 0.20
  17. Thierry Conroy · 1 shared paper, 2025 · strength 0.20
  18. Akeila Bellahcène · 1 shared paper, 2025 · strength 0.20
  19. Rebekah Crake · 1 shared paper, 2025 · strength 0.20
  20. Jerome F. Cros · 1 shared paper, 2025 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.